Literature DB >> 10631971

Changing the surface of a virus shell fusion of an enzyme to polyoma VP1.

S Gleiter1, K Stubenrauch, H Lilie.   

Abstract

Recent developments on virus-like particles have demonstrated their potential in transfecting eucaryotic cells. In the case of particles based on the major coat protein VP1 of polyoma virus, transfection occurs via binding of VP1 to sialic acids. Since sialic acid is present on almost every eucaryotic cell line, this results in an unspecific cell targeting. Generation of a cell-type specificity of this system would imply the presentation of a new function on the surface of VP1. To analyze whether a new functional protein can be placed on VP1, we inserted dihydrofolate reductase from Escherichia coli as a model protein. The effect of such an insertion on both VP1 and the inserted protein was investigated, respectively. The function of VP1, like the formation of pentameric capsomers and its ability to assemble into capsids, was not influenced by the insertion. The inserted dihydrofolate reductase showed major changes when compared to the wild-type form. The thermal stability of the enzyme was dramatically reduced in the fusion protein; nevertheless, the dihydrofolate reductase proved to be a fully active enzyme with only slightly increased K(M) values for its substrates. This model system provides the basis for further modifications of the VP1 protein to achieve an altered surface of VP1 with new properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631971      PMCID: PMC2144229          DOI: 10.1110/ps.8.12.2562

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  A COMPARATIVE STUDY OF POLYOMA AND PAPILLOMA VIRUSES.

Authors:  L V CRAWFORD; E M CRAWFORD
Journal:  Virology       Date:  1963-10       Impact factor: 3.616

2.  Random circular permutation of DsbA reveals segments that are essential for protein folding and stability.

Authors:  J Hennecke; P Sebbel; R Glockshuber
Journal:  J Mol Biol       Date:  1999-03-05       Impact factor: 5.469

3.  Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.

Authors:  F Martin; J Kupsch; Y Takeuchi; S Russell; F L Cosset; M Collins
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

4.  Selection for a periplasmic factor improving phage display and functional periplasmic expression.

Authors:  H Bothmann; A Plückthun
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

5.  Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids.

Authors:  E Soeda; N Krauzewicz; C Cox; J Stokrová; J Forstová; B E Griffin
Journal:  Gene Ther       Date:  1998-10       Impact factor: 5.250

6.  Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody.

Authors:  H Konishi; T Ochiya; K A Chester; R H Begent; T Muto; T Sugimura; M Terada; R H Begent
Journal:  Hum Gene Ther       Date:  1998-01-20       Impact factor: 5.695

7.  Amplification of ColE1 related plasmids in recombinant cultures of Escherichia coli after IPTG induction.

Authors:  A Teich; H Y Lin; L Andersson; S Meyer; P Neubauer
Journal:  J Biotechnol       Date:  1998-10-08       Impact factor: 3.307

8.  Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli.

Authors:  H Braun; K Boller; J Löwer; W M Bertling; A Zimmer
Journal:  Biotechnol Appl Biochem       Date:  1999-02       Impact factor: 2.431

9.  Making antibody fragments using phage display libraries.

Authors:  T Clackson; H R Hoogenboom; A D Griffiths; G Winter
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

10.  Structure and function of the Bacillus hybrid enzyme GluXyn-1: native-like jellyroll fold preserved after insertion of autonomous globular domain.

Authors:  J Aÿ; F Götz; R Borriss; U Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more
  8 in total

1.  Coupling of antibodies via protein Z on modified polyoma virus-like particles.

Authors:  S Gleiter; H Lilie
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

2.  Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles.

Authors:  K Stubenrauch; S Gleiter; U Brinkmann; R Rudolph; H Lilie
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

3.  Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.

Authors:  Young C Shin; William R Folk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

Review 5.  Platform technologies for modern vaccine manufacturing.

Authors:  Hayley K Charlton Hume; Linda H L Lua
Journal:  Vaccine       Date:  2017-03-25       Impact factor: 3.641

Review 6.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

7.  Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid.

Authors:  Yingbing Liang; Hiroto Furukawa; Kentarou Sakamoto; Hiroshi Inaba; Kazunori Matsuura
Journal:  Chembiochem       Date:  2022-06-21       Impact factor: 3.461

8.  Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.

Authors:  Thomas Schumacher; Claus Ruehland; Christine Schultheiss; Marc Brinkman; Franz Roedel; Christian O A Reiser; Juergen Hess; Christoph Reichel
Journal:  Int J Biomed Sci       Date:  2007-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.